DR. FRANCISCO ANTONIO PADILLA QUIROZ M.D.
Prescription History 1831399310
Internal Medicine - Endocrinology, Diabetes & Metabolism in Seaford, DE

NPI Status: Active since July 23, 2007

Contact Information

100 RAWLINS DR
SEAFORD, DE
ZIP 19973
Phone: (302) 629-0452

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. FRANCISCO ANTONIO PADILLA QUIROZ M.D., an active Endocrinology, Diabetes & Metabolism specialist practicing in Seaford, DE. Our medical registry currently tracks 69 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 5,326 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 647 claims alone.


Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 94
30-Day Fills 256.0
Days Supply 7,680
DE State Average Benchmarks
Peer Average Claims191.0
Peer Average 30-Day Fills497.1
Peer Average Days Supply14,836
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 50.8% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,899.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.21

State Avg Cost Per Claim

$15.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Basaglar Kwikpen U-100

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 46
30-Day Fills 92.3
Days Supply 2,752
DE State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills51.7
Peer Average Days Supply1,397
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 58.6% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $15,216.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$330.80

State Avg Cost Per Claim

$381.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Calcitriol

Generic Formulation: CalcitriolSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 24.6
Days Supply 730
DE State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills116.3
Peer Average Days Supply3,450
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 70.8% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $148.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.59

State Avg Cost Per Claim

$28.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.

Therapeutic Applications

Calcitriol is a man-made active form of vitamin D. Most people get enough vitamin D from exposure to the sun and from fortified food products (such as dairy products, vitamins). Vitamin D helps control parathyroid hormone and the levels of certain minerals (such as calcium, phosphorus) that are needed for building and keeping strong bones. Before regular vitamin D can be used by the body, it needs to be changed to the active form by the liver and kidneys. Calcitriol is used in patients with kidney disease who can't make enough of the active form of Vitamin D. This medication is also used to prevent and treat certain types of calcium/phosphorus/parathyroid problems that can happen with long-term kidney dialysis or hypoparathyroidism. Calcitriol is usually used along with specific diet recommendations and sometimes other medications.

Dexamethasone

Generic Formulation: DexamethasoneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 15
DE State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills29.7
Peer Average Days Supply445
Conservative Utilization

This provider writes prescriptions for this formulation 44.4% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$0.76

State Avg Cost Per Claim

$17.64

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory 9-fluoro-glucocorticoid.

Therapeutic Applications

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Droplet Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 79
30-Day Fills 222.9
Days Supply 6,670
DE State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills63.8
Peer Average Days Supply1,904
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 243.5% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,561.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$108.37

State Avg Cost Per Claim

$86.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Estradiol

Generic Formulation: EstradiolSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 12
30-Day Fills 14.0
Days Supply 386
DE State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills86.7
Peer Average Days Supply2,586
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 63.6% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $342.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$28.54

State Avg Cost Per Claim

$116.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

Therapeutic Applications

This medication is a female hormone (estrogen). It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment.

Euthyrox

Generic Formulation: Levothyroxine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 15
30-Day Fills 38.3
Days Supply 1,150
DE State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills48.3
Peer Average Days Supply1,448
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $86.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.77

State Avg Cost Per Claim

$6.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Farxiga

Generic Formulation: Dapagliflozin PropanediolSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 77
30-Day Fills 179.7
Days Supply 5,390
DE State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills67.9
Peer Average Days Supply2,010
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 133.3% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $99,035.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,286.18

State Avg Cost Per Claim

$1,125.55

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys.

Fiasp Flextouch

Generic Formulation: Insulin Aspart (Niacinamide)Specialty: Endocrinology
Provider Metrics Summary
Total Claims 25
30-Day Fills 40.4
Days Supply 1,199
DE State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills36.6
Peer Average Days Supply996
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $28,580.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,143.23

State Avg Cost Per Claim

$1,222.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Finasteride

Generic Formulation: FinasterideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 11
30-Day Fills 13.0
Days Supply 343
DE State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills133.1
Peer Average Days Supply3,965
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 78.4% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $118.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.81

State Avg Cost Per Claim

$18.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.

Therapeutic Applications

Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication.

Glimepiride

Generic Formulation: GlimepirideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 95
30-Day Fills 203.0
Days Supply 6,090
DE State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills100.0
Peer Average Days Supply2,987
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 150.0% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $947.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.97

State Avg Cost Per Claim

$12.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family.

Therapeutic Applications

Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide

Generic Formulation: GlipizideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 34
30-Day Fills 99.7
Days Supply 2,970
DE State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills68.1
Peer Average Days Supply2,022
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $353.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.40

State Avg Cost Per Claim

$10.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide Er

Generic Formulation: GlipizideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 99
30-Day Fills 241.7
Days Supply 7,228
DE State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills86.4
Peer Average Days Supply2,582
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 200.0% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,837.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.56

State Avg Cost Per Claim

$21.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Humalog

Generic Formulation: Insulin LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 41
30-Day Fills 80.8
Days Supply 2,420
DE State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills38.9
Peer Average Days Supply950
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 64.0% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $53,042.09 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,293.71

State Avg Cost Per Claim

$736.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 90
30-Day Fills 154.9
Days Supply 4,507
DE State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills69.8
Peer Average Days Supply2,004
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 172.7% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $94,169.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,046.32

State Avg Cost Per Claim

$1,155.50

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Mix 75-25

Generic Formulation: Insulin Lispro Protamin/LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 18
30-Day Fills 25.6
Days Supply 770
DE State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills16.7
Peer Average Days Supply450
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.5% more claims than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $14,725.08 across this reporting matrix range.

Provider Avg Cost Per Claim

$818.06

State Avg Cost Per Claim

$927.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Humalog Mix 75-25 Kwikpen

Generic Formulation: Insulin Lispro Protamin/LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 82
30-Day Fills 155.5
Days Supply 4,494
DE State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills50.6
Peer Average Days Supply1,453
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 215.4% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $96,797.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,180.46

State Avg Cost Per Claim

$1,346.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Humulin 70-30

Generic Formulation: Insulin Nph Hum/Reg Insulin HmSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 16
30-Day Fills 20.4
Days Supply 553
DE State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills22.0
Peer Average Days Supply481
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,504.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$344.05

State Avg Cost Per Claim

$258.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Humulin R U-500 Kwikpen

Generic Formulation: Insulin Regular, HumanSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 15
30-Day Fills 19.5
Days Supply 571
DE State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills46.8
Peer Average Days Supply1,270
Conservative Utilization

This provider writes prescriptions for this formulation 48.3% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,852.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$923.52

State Avg Cost Per Claim

$1,907.98

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin).

Hydrocortisone

Generic Formulation: HydrocortisoneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 33
30-Day Fills 56.3
Days Supply 1,690
DE State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills33.9
Peer Average Days Supply771
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,203.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$36.47

State Avg Cost Per Claim

$20.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

Therapeutic Applications

Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal.

Ibandronate Sodium

Generic Formulation: Ibandronate SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 38
30-Day Fills 103.4
Days Supply 3,015
DE State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills58.2
Peer Average Days Supply1,744
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 72.7% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,394.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$36.70

State Avg Cost Per Claim

$75.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.

Therapeutic Applications

Ibandronate is used to prevent and treat certain types of bone loss (osteoporosis). Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause, as you age, or if you take corticosteroid medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Ibandronate belongs to a class of medications called bisphosphonates.

Insulin Aspart Flexpen

Generic Formulation: Insulin AspartSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 19
30-Day Fills 32.0
Days Supply 941
DE State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills33.7
Peer Average Days Supply838
Conservative Utilization

This provider writes prescriptions for this formulation 26.9% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,733.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$459.66

State Avg Cost Per Claim

$295.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Insulin Lispro Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 31
30-Day Fills 51.8
Days Supply 1,526
DE State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills33.4
Peer Average Days Supply833
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 40.9% more claims than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,877.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$254.12

State Avg Cost Per Claim

$201.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Insulin Lispro Protamine Mix

Generic Formulation: Insulin Lispro Protamin/LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 24
30-Day Fills 26.2
Days Supply 733
DE State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills21.8
Peer Average Days Supply478
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 33.3% more claims than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,665.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$319.39

State Avg Cost Per Claim

$206.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Insulin Syringe

Generic Formulation: Syringe And Needle,insulin,1mlSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 15
30-Day Fills 35.8
Days Supply 1,073
DE State Average Benchmarks
Peer Average Claims11.0
Peer Average 30-Day Fills29.0
Peer Average Days Supply825
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 36.4% more claims than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $645.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.05

State Avg Cost Per Claim

$29.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Janumet

Generic Formulation: Sitagliptin Phos/Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 18
30-Day Fills 30.0
Days Supply 900
DE State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills40.2
Peer Average Days Supply1,186
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $15,921.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$884.54

State Avg Cost Per Claim

$1,044.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. This product contains 2 medications. Sitagliptin works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Januvia

Generic Formulation: Sitagliptin PhosphateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 59
30-Day Fills 111.0
Days Supply 3,313
DE State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills63.3
Peer Average Days Supply1,843
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 96.7% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $60,084.64 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,018.38

State Avg Cost Per Claim

$1,079.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.

Therapeutic Applications

Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes.

Jardiance

Generic Formulation: EmpagliflozinSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 302
30-Day Fills 548.0
Days Supply 16,388
DE State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills81.4
Peer Average Days Supply2,403
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 694.7% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $328,873.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,088.98

State Avg Cost Per Claim

$1,236.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys.

Lantus

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 26.9
Days Supply 788
DE State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills32.3
Peer Average Days Supply847
Conservative Utilization

This provider writes prescriptions for this formulation 44.0% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,538.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$824.21

State Avg Cost Per Claim

$448.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Lantus Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 178
30-Day Fills 389.3
Days Supply 11,563
DE State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills71.3
Peer Average Days Supply2,048
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 408.6% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $108,319.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$608.54

State Avg Cost Per Claim

$611.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Levemir Flexpen

Generic Formulation: Insulin DetemirSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 93
30-Day Fills 197.9
Days Supply 5,918
DE State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$819.58

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide).

Levemir Flextouch

Generic Formulation: Insulin DetemirSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 25.4
Days Supply 708
DE State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills46.3
Peer Average Days Supply1,305
Conservative Utilization

This provider writes prescriptions for this formulation 44.0% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,896.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$635.45

State Avg Cost Per Claim

$716.01

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide).

Levothyroxine Sodium

Generic Formulation: Levothyroxine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 647
30-Day Fills 1,760.3
Days Supply 52,629
DE State Average Benchmarks
Peer Average Claims133.0
Peer Average 30-Day Fills336.7
Peer Average Days Supply10,014
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 386.5% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,813.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.26

State Avg Cost Per Claim

$16.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Liothyronine Sodium

Generic Formulation: Liothyronine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 12
30-Day Fills 34.0
Days Supply 993
DE State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills69.5
Peer Average Days Supply2,053
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.1% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $596.43 across this reporting matrix range.

Provider Avg Cost Per Claim

$49.70

State Avg Cost Per Claim

$56.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.

Therapeutic Applications

Liothyronine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally made by the thyroid gland. Liothyronine is a man-made form of thyroid hormone. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone helps you stay healthy. For children, having enough thyroid hormone helps them grow and learn normally. This medication is also used to treat other types of thyroid problems (such as certain types of goiters, thyroid cancer). It can also be used to test for certain types of thyroid disease. This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Lyumjev Kwikpen U-100

Generic Formulation: Insulin Lispro-AabcSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.2
Days Supply 332
DE State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills36.1
Peer Average Days Supply1,055
Conservative Utilization

This provider writes prescriptions for this formulation 26.3% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,721.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$551.55

State Avg Cost Per Claim

$1,092.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin lispro-aabc is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro-aabc is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro-aabc starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro-aabc may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Medroxyprogesterone Acetate

Generic Formulation: Medroxyprogesterone AcetateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 13
30-Day Fills 15.0
Days Supply 402
DE State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills38.6
Peer Average Days Supply1,129
Conservative Utilization

This provider writes prescriptions for this formulation 27.8% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $128.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.88

State Avg Cost Per Claim

$29.35

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.

Therapeutic Applications

This medication is used to prevent pregnancy. Medroxyprogesterone is like a natural hormone made by the body. Using this medication does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia).

Metformin Hcl

Generic Formulation: Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 294
30-Day Fills 746.7
Days Supply 22,260
DE State Average Benchmarks
Peer Average Claims89.0
Peer Average 30-Day Fills228.9
Peer Average Days Supply6,834
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 230.3% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,256.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.08

State Avg Cost Per Claim

$9.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Metformin Hcl Er

Generic Formulation: Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 243
30-Day Fills 689.9
Days Supply 20,640
DE State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills120.1
Peer Average Days Supply3,592
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 440.0% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,687.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.29

State Avg Cost Per Claim

$12.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Methimazole

Generic Formulation: MethimazoleSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 159
30-Day Fills 391.5
Days Supply 11,628
DE State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills74.4
Peer Average Days Supply2,199
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 381.8% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,729.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.87

State Avg Cost Per Claim

$13.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.

Therapeutic Applications

Methimazole is used to treat overactive thyroid (hyperthyroidism). It works by stopping the thyroid gland from making too much thyroid hormone.

Mounjaro

Generic Formulation: TirzepatideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 23
30-Day Fills 24.8
Days Supply 700
DE State Average Benchmarks
Peer Average Claims11.0
Peer Average 30-Day Fills18.2
Peer Average Days Supply532
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 109.1% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27,553.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,197.99

State Avg Cost Per Claim

$1,772.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS.

Therapeutic Applications

Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes.

Nano 2nd Gen Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 183
30-Day Fills 510.5
Days Supply 15,291
DE State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills88.3
Peer Average Days Supply2,627
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 438.2% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $22,877.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$125.01

State Avg Cost Per Claim

$114.98

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Novolog

Generic Formulation: Insulin AspartSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 58
30-Day Fills 77.3
Days Supply 2,280
DE State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills43.6
Peer Average Days Supply1,222
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 132.0% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $71,522.64 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,233.15

State Avg Cost Per Claim

$1,032.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Novolog Flexpen

Generic Formulation: Insulin AspartSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 215
30-Day Fills 371.2
Days Supply 10,860
DE State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills73.0
Peer Average Days Supply2,063
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 465.8% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $238,401.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,108.84

State Avg Cost Per Claim

$1,120.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Novolog Mix 70-30

Generic Formulation: Insulin Aspart Prot/Insuln AspSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 19
30-Day Fills 26.0
Days Supply 780
DE State Average Benchmarks
Peer Average Claims15.0
Peer Average 30-Day Fills16.9
Peer Average Days Supply463
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 26.7% more claims than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $25,249.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,328.92

State Avg Cost Per Claim

$635.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin aspart protamine/insulin aspart is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. This product is a combination of two man-made insulins: intermediate-acting insulin aspart protamine and rapid-acting insulin aspart. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Novolog Mix 70-30 Flexpen

Generic Formulation: Insulin Aspart Prot/Insuln AspSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 84
30-Day Fills 142.0
Days Supply 4,187
DE State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills53.8
Peer Average Days Supply1,510
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 189.7% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $96,154.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,144.70

State Avg Cost Per Claim

$1,319.84

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin aspart protamine/insulin aspart is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. This product is a combination of two man-made insulins: intermediate-acting insulin aspart protamine and rapid-acting insulin aspart. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Omnipod 5 G6 Pods (Gen 5)

Generic Formulation: Insulin Pump Cart,automated,btSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 32
30-Day Fills 60.0
Days Supply 1,800
DE State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$1,059.08

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ozempic

Generic Formulation: SemaglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 435
30-Day Fills 579.2
Days Supply 16,710
DE State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills80.7
Peer Average Days Supply2,375
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 866.7% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $518,955.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,193.00

State Avg Cost Per Claim

$1,659.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Pioglitazone Hcl

Generic Formulation: Pioglitazone HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 53
30-Day Fills 131.0
Days Supply 3,930
DE State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills79.3
Peer Average Days Supply2,374
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 76.7% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $961.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.15

State Avg Cost Per Claim

$20.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone.

Pravastatin Sodium

Generic Formulation: Pravastatin SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 18
30-Day Fills 48.0
Days Supply 1,405
DE State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills143.0
Peer Average Days Supply4,274
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 66.0% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $309.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.21

State Avg Cost Per Claim

$18.47

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).

Therapeutic Applications

Pravastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Prednisone

Generic Formulation: PrednisoneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 16
30-Day Fills 39.3
Days Supply 1,095
DE State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills59.8
Peer Average Days Supply1,073
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 66.7% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $323.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.22

State Avg Cost Per Claim

$6.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Repaglinide

Generic Formulation: RepaglinideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 12
30-Day Fills 20.0
Days Supply 600
DE State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills64.7
Peer Average Days Supply1,925
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.1% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $197.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.48

State Avg Cost Per Claim

$62.33

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Repaglinide is used alone or with other medications to control high blood sugar along with a proper diet and exercise program. It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. It works by stimulating the body to produce more insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet.

Rosuvastatin Calcium

Generic Formulation: Rosuvastatin CalciumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 24
30-Day Fills 70.0
Days Supply 2,100
DE State Average Benchmarks
Peer Average Claims117.0
Peer Average 30-Day Fills324.2
Peer Average Days Supply9,709
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 79.5% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,105.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$46.08

State Avg Cost Per Claim

$38.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.

Therapeutic Applications

Rosuvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details.

Rybelsus

Generic Formulation: SemaglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 82
30-Day Fills 141.0
Days Supply 4,230
DE State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills36.2
Peer Average Days Supply1,084
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 331.6% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $134,938.23 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,645.59

State Avg Cost Per Claim

$1,719.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Soliqua 100-33

Generic Formulation: Insulin Glargine/LixisenatideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 52
30-Day Fills 66.8
Days Supply 1,992
DE State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills44.2
Peer Average Days Supply1,291
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 126.1% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $55,246.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,062.42

State Avg Cost Per Claim

$1,161.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is a combination of insulin glargine and lixisenatide and is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Lixisenatide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar levels (such as after a meal) and decreasing the amount of sugar your liver makes.

Synjardy Xr

Generic Formulation: Empagliflozin/Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 22
30-Day Fills 40.0
Days Supply 1,200
DE State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills43.6
Peer Average Days Supply1,302
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $24,862.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,130.12

State Avg Cost Per Claim

$1,373.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is a combination of 2 drugs: empagliflozin and metformin. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines.

Synthroid

Generic Formulation: Levothyroxine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 166
30-Day Fills 416.5
Days Supply 12,271
DE State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills113.3
Peer Average Days Supply3,392
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 315.0% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,486.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$69.20

State Avg Cost Per Claim

$62.49

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Testosterone Cypionate

Generic Formulation: Testosterone CypionateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 11
30-Day Fills 20.3
Days Supply 586
DE State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills39.5
Peer Average Days Supply1,150
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $606.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$55.16

State Avg Cost Per Claim

$51.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used in men who do not make enough of a natural substance called testosterone. In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. It may also be used to treat certain types of breast cancer in women.

Toujeo Max Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 72
30-Day Fills 119.6
Days Supply 3,520
DE State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills32.8
Peer Average Days Supply899
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 323.5% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $84,871.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,178.77

State Avg Cost Per Claim

$940.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Toujeo Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 92
30-Day Fills 193.7
Days Supply 5,679
DE State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills50.1
Peer Average Days Supply1,459
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 318.2% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $66,231.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$719.91

State Avg Cost Per Claim

$811.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Tradjenta

Generic Formulation: LinagliptinSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 38
30-Day Fills 68.5
Days Supply 2,056
DE State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills52.1
Peer Average Days Supply1,447
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 35.7% more claims than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $38,487.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,012.84

State Avg Cost Per Claim

$904.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.

Therapeutic Applications

Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes.

Tresiba Flextouch U-100

Generic Formulation: Insulin DegludecSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 66
30-Day Fills 138.3
Days Supply 4,138
DE State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills72.7
Peer Average Days Supply2,132
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 106.3% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $35,530.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$538.34

State Avg Cost Per Claim

$777.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Tresiba Flextouch U-200

Generic Formulation: Insulin DegludecSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 108
30-Day Fills 227.0
Days Supply 6,781
DE State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills54.0
Peer Average Days Supply1,575
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 332.0% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $107,666.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$996.91

State Avg Cost Per Claim

$1,301.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Trulicity

Generic Formulation: DulaglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 211
30-Day Fills 273.9
Days Supply 7,876
DE State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills80.7
Peer Average Days Supply2,362
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 379.5% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $273,499.01 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,296.20

State Avg Cost Per Claim

$1,728.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment.

Ultra-Fine Mini Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 13
30-Day Fills 38.7
Days Supply 1,162
DE State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills68.8
Peer Average Days Supply2,043
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.9% less volume than the regional standard for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,331.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$102.41

State Avg Cost Per Claim

$98.14

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultra-Fine Nano Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 40
30-Day Fills 115.2
Days Supply 3,455
DE State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills63.0
Peer Average Days Supply1,866
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 53.8% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,723.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$118.09

State Avg Cost Per Claim

$92.44

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultra-Fine Short Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 12
30-Day Fills 36.0
Days Supply 1,080
DE State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills49.1
Peer Average Days Supply1,455
Conservative Utilization

This provider writes prescriptions for this formulation 40.0% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,528.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$127.36

State Avg Cost Per Claim

$101.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultracare Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 13
30-Day Fills 23.0
Days Supply 650
DE State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills30.0
Peer Average Days Supply840
Conservative Utilization

This provider writes prescriptions for this formulation 27.8% less frequently than the standard regional baseline metric for practitioners inside DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $855.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$65.79

State Avg Cost Per Claim

$50.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Victoza 3-Pak

Generic Formulation: LiraglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 41
30-Day Fills 74.0
Days Supply 2,220
DE State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills44.0
Peer Average Days Supply1,300
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 78.3% higher than the standard regional baseline profile for DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $75,901.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,851.25

State Avg Cost Per Claim

$1,940.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

Therapeutic Applications

This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

Xultophy 100-3.6

Generic Formulation: Insulin Degludec/LiraglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 17
30-Day Fills 29.2
Days Supply 869
DE State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills29.2
Peer Average Days Supply863
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across DE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $25,545.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,502.68

State Avg Cost Per Claim

$1,711.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is a combination of insulin degludec and liraglutide and is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Liraglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar levels (such as after a meal) and decreasing the amount of sugar your liver makes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. FRANCISCO ANTONIO PADILLA QUIROZ M.D. provides transparency into local medical care patterns within Seaford, DE.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Endocrinology, Diabetes & Metabolism** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.